Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
Abbot Financial Management Inc. Purchases Shares of 8,550 G1 Therapeutics Inc (NASDAQ:GTHX)
09:19am, Saturday, 07'th Mar 2020
Abbot Financial Management Inc. purchased a new stake in G1 Therapeutics Inc (NASDAQ:GTHX) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The
G1 Therapeutics (NASDAQ:GTHX) Upgraded by Zacks Investment Research to Hold
07:58am, Saturday, 07'th Mar 2020
Zacks Investment Research upgraded shares of G1 Therapeutics (NASDAQ:GTHX) from a sell rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks,
ValuEngine Downgrades G1 Therapeutics (NASDAQ:GTHX) to Hold
08:42am, Monday, 02'nd Mar 2020
G1 Therapeutics (NASDAQ:GTHX) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, ValuEngine reports. G
Wedbush Analysts Reduce Earnings Estimates for G1 Therapeutics Inc (NASDAQ:GTHX)
06:48am, Monday, 02'nd Mar 2020
G1 Therapeutics Inc (NASDAQ:GTHX) – Stock analysts at Wedbush decreased their Q1 2020 earnings per share (EPS) estimates for G1 Therapeutics in a note issued to investors on Thursday, February 27th.
Fmr LLC Has $148.99 Million Stock Position in G1 Therapeutics Inc (NASDAQ:GTHX)
12:38pm, Friday, 28'th Feb 2020
Fmr LLC boosted its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
G1 Therapeutics (NASDAQ:GTHX) Upgraded by BidaskClub to "Sell"
06:46am, Friday, 28'th Feb 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Friday, BidAskClub reports. S
Analysts Are Bullish on Top Healthcare Stocks: G1 Therapeutics (GTHX), GW Pharma (GWPH)
12:05pm, Thursday, 27'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on G1 Therapeutics (GTHX) and GW Pharma (GWPH) with bullish
G1 Therapeutics (GTHX) Receives a Buy from Cowen & Co.
08:49am, Thursday, 27'th Feb 2020
Cowen & Co. analyst Chris Shibutani assigned a Buy rating to G1 Therapeutics (GTHX) yesterday. The company's shares closed last Monday at $17.46,
G1 Therapeutics Inc (NASDAQ:GTHX) Receives Consensus Recommendation of "Buy" from Brokerages
08:34am, Thursday, 27'th Feb 2020
Shares of G1 Therapeutics Inc (NASDAQ:GTHX) have received an average rating of “Buy” from the ten research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rat
G1 Therapeutics, Inc. (GTHX) Q4 2019 Earnings Call Transcript
07:31am, Thursday, 27'th Feb 2020
GTHX earnings call for the period ending December 31, 2019.
G1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q4 2019 Results - Earnings Call Transcript
02:50am, Thursday, 27'th Feb 2020
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2019 Earnings Conference Call February 26, 2020 4:30 PM ET Company Participants Jeff Macdonald - Senior Director of Inves
BRIEF-G1 Therapeutics Says Rintodestrant Combination Trial With Palbociclib Expected To Initiate In Q2
10:32pm, Wednesday, 26'th Feb 2020
G1 Therapeutics Inc:
G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update
09:01pm, Wednesday, 26'th Feb 2020
New Drug Application (NDA) submission for trilaciclib in small cell lung cancer on track for 2Q20Trilaciclib selected for inclusion in I-SPY 2 breast cancer trialRintodestrant.
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
02:36pm, Wednesday, 26'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 25) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) (Cowen
Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus
07:59pm, Monday, 24'th Feb 2020
Stock markets took a hit Monday from growing concerns over the spread of the coronavirus.
